AI-generated summary
The authors studied MCF-7 breast cancer cells exposed to low-level lasers at blue, red and near-infrared wavelengths across several power levels and durations, measuring viability with WST-1 assays. They report that cell viability varied by wavelength and dose, with the infrared laser at 25 mW for 900 s giving the lowest viability, 32.53%. The study was conducted on cell cultures rather than people.
- Who or what was studied
- MCF-7 breast cancer cell line cultures
- Wavelengths
- 473, 660, 780 nm
- Limits stated in the abstract
- The study used cell cultures only, so results may not translate to human patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 473 nm, 660 nm, 780 nm
- Power
- 65 mW, 45 mW, 10 mW, 25 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Wavelength, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.